Breaking News

Crown Biosciences Opens Facility in China

Full operational capacity is expected in early 2021.

By: Contract Pharma

Contract Pharma Staff

Crown Bioscience, a JSR Life Sciences company, has opened a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand.   Once completed, this new building will add more than 2,000m2 of new vivarium space to support CrownBio’s in vivo oncology platforms, helping satisfy predicted near-term growth.   CrownBio’s products and services are used by pharmaceutical and biotech customers across APAC, North America, and Europe to accelerate and de-risk their drug disc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters